Bank Negara Indonesia Tbk (BBNI JK) stock market data APIs

Rp3975.9187 -44.1(-1.1%)
as of July 4, 2025
Try our APIs with free plan!

Bank Negara Indonesia Tbk Financial Data Overview

Price chart is built with Anychart

PT Bank Negara Indonesia (Persero) Tbk, together with its subsidiaries, provides various banking products and services in Indonesia, rest of Asia, New York, and Europe. It operates through Wholesale and International Banking, Institutional Banking, Enterprises and Commercial Banking, Retail Banking, Treasury, and Subsidiaries segments. The company offers savings; savings plan and FIPF products; loans; credit cards; bancassurance, payroll, and simulation services; safe deposit boxes, bank references, bonds, foreign bank notes, and mobile banking services; services to collect payments or valuable documents; and Xpora, a digital solution for small and medium enterprises. It also provides business banking, funding, lending, trade finance, smart remittance, foreign direct investment, collection and liquidity management, payment management, supply chain financing, consumer financing, wealth management, and custody and trust services; financial institution products; solutions for industrial sectors; and treasury products. In addition, the company offers insurance and venture capital services; securities; and ATM, phone and SMS banking, mobile and internet banking, and internet payment gateway services. PT Bank Negara Indonesia (Persero) Tbk was founded in 1946 and is headquartered in Jakarta Pusat, Indonesia.

Prev. Close 3975.9187
Open 3931.816
High 3997.8196
Low 3920.4142
52 wk Range 3313.2203-5369.069
Market Cap 149 027 195 M
P/E Ratio 6.93
Shares Outstanding 579 M
Revenue 50 768 300 M
EPS 144
Dividends (Yield) 0.0908
Beta 0.38

Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Bank Negara Indonesia Tbk data using free add-ons & libraries


Get Bank Negara Indonesia Tbk Fundamental Data

Bank Negara Indonesia Tbk Fundamental data includes:

  • Net Revenue: 50 768 300 M
  • EBITDA:
  • Earnings Per Share: 577
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Bank Negara Indonesia Tbk Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2025-04-25
  • EPS/Forecast: 156.06
GET THE PACKAGE

Get Bank Negara Indonesia Tbk End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Bank Negara Indonesia Tbk News

PT Bank Negara Indonesia (Persero) Tbk (PTBRY) Q3 2024 Earnings Call Highlights: Strong Loan ... New

PT Bank Negara Indonesia (Persero) Tbk (PTBRY) Q3 2024 Earnings Call Highlights: Strong Loan ...

Release Date: October 25, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points PT Bank Negara Indonesia (Persero) Tbk (PTBRY) re...

SSMS Plantation Holdings Pte. Ltd. -- Moody's downgrades Sawit Sumbermas to Caa1; outlook remains negative

SSMS Plantation Holdings Pte. Ltd. -- Moody's downgrades Sawit Sumbermas to Caa1; outlook remains negative

Rating Action: Moody's downgrades Sawit Sumbermas to Caa1; outlook remains negativeGlobal Credit Research - 11 Jan 2022Singapore, January 11, 2022 -- Moody's Investors Service has downgraded the corpo...

Akero Therapeutics Presents Analyses at the 2021 International Liver Congress Showing Normalization of Liver Fat Substantially Reduced Markers of Liver Injury and Fibrosis, and Greatly Increased Probability of Resolving NASH

Akero Therapeutics Presents Analyses at the 2021 International Liver Congress Showing Normalization of Liver Fat Substantially Reduced Markers of Liver Injury and Fibrosis, and Greatly Increased Probability of Resolving NASH

Analyses also Show that Combining a Threshold for ALT Reduction of ≥17 U/L with Normalization of Liver Fat Improves Predictive Power for Resolution of NASH with 1-Stage Improvement of Fibrosis SOUT...

Akero Therapeutics Presents Analyses at the 2021 International Liver Congress Showing Normalization of Liver Fat Substantially Reduced Markers of Liver Injury and Fibrosis, and Greatly Increased Probability of Resolving NASH

Akero Therapeutics Presents Analyses at the 2021 International Liver Congress Showing Normalization of Liver Fat Substantially Reduced Markers of Liver Injury and Fibrosis, and Greatly Increased Probability of Resolving NASH

Analyses also Show that Combining a Threshold for ALT Reduction of ≥17 U/L with Normalization of Liver Fat Improves Predictive Power for Resolution of NASH with 1-Stage Improvement of Fibrosis SOUT...

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat